XNASZIMV
Market cap378mUSD
Jan 07, Last price
13.72USD
1D
-2.21%
1Q
-12.94%
IPO
-51.00%
Name
ZimVie Inc
Chart & Performance
P/E
—
P/S
0.83
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
0.27%
Rev. gr., 5y
-16.08%
Revenues
457m
-49.95%
Net income
-393m
L+515.65%
CFO
37m
+50.84%
Earnings
May 15, 2025
Profile
ZimVie Inc., a medical technology company, develops, manufactures, and delivers a portfolio of products and solutions designed to treat a range of spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; bone grafts, barrier membranes, allografts, and collagen wound care products; intraoral scanners; and virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and patient-specific restorative components and intra-oral scanners, as well as spinal fusion implants and instrumentation for various spinal procedures, biologics, and bone healing technologies. The company also provides MIS solutions, such as Vital MIS and Timberline; and motion preservation solutions, including Mobi-C and The Tether. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | ||||||
Revenues | 457,433 -49.95% | 913,862 -9.93% | ||||
Cost of revenue | 193,212 | 363,477 | ||||
Unusual Expense (Income) | ||||||
NOPBT | 264,221 | 550,385 | ||||
NOPBT Margin | 57.76% | 60.23% | ||||
Operating Taxes | 5,202 | (46,038) | ||||
Tax Rate | 1.97% | |||||
NOPAT | 259,019 | 596,423 | ||||
Net income | (393,282) 515.65% | (63,881) -32.97% | ||||
Dividends | (540,567) | |||||
Dividend yield | 221.89% | |||||
Proceeds from repurchase of equity | ||||||
BB yield | ||||||
| Debt | ||||||
Debt current | 4,053 | 9,617 | ||||
Long-term debt | 531,010 | 576,807 | ||||
Deferred revenue | ||||||
Other long-term liabilities | 104,096 | 13,561 | ||||
Net debt | 463,552 | 496,823 | ||||
| Cash flow | ||||||
Cash from operating activities | 37,148 | 24,628 | ||||
CAPEX | (12,487) | (26,546) | ||||
Cash from investing activities | (15,174) | (28,663) | ||||
Cash from financing activities | (25,666) | (1,307) | ||||
FCF | 349,193 | 652,014 | ||||
| Balance | ||||||
Cash | 71,511 | 89,601 | ||||
Long term investments | ||||||
Excess cash | 48,639 | 43,908 | ||||
Stockholders' equity | (513,503) | (138,424) | ||||
Invested Capital | 1,549,022 | 1,460,370 | ||||
ROIC | 17.21% | 40.04% | ||||
ROCE | 25.51% | 38.76% | ||||
| EV | ||||||
Common stock shares outstanding | 26,454 | 26,083 | ||||
Price | 17.75 90.04% | 9.34 | ||||
Market cap | 469,558 92.75% | 243,615 | ||||
EV | 933,110 | 740,438 | ||||
EBITDA | 385,907 | 673,174 | ||||
EV/EBITDA | 2.42 | 1.10 | ||||
Interest | 20,234 | 18,279 | ||||
Interest/NOPBT | 7.66% | 3.32% | ||||